Literature DB >> 1583926

Ongoing assessment of health status in patients with diabetes mellitus.

D R Nerenz1, D P Repasky, F W Whitehouse, D M Kahkonen.   

Abstract

In 1990, the Division of Endocrinology and Metabolism of Henry Ford Hospital established an Outcomes Management data base for patients with Type I and Type II diabetes. A first cohort of 117 patients completed a baseline and 6-month follow-up assessment; a second cohort of 116 patients completed the baseline assessment. Assessment at each time point includes: the Short Form--36 Questions (SF-36) health status instrument; a set of clinical variables known as the Diabetes TyPE scale Form 2.2 abstracted from the medical record; and the physicians' ratings of patient's health status along the major dimensions of the SF-36. Success with both face-to-face and mailed administration of the SF-36 has been good, with response rates of over 85% using both methods. Comparison of patient and physician ratings of patient health status indicated a significant discrepancy on ratings of general health status, with physicians' ratings higher than those of patients themselves. "Tight" glycemic control (as measured by glycosylated hemoglobin) was associated with somewhat lower ratings on the various SF-36 dimensions for all patients in the first cohort and for Type I patients in the second cohort. However, this effect did not seem to be attributable to those features of a complex regimen used to achieve tight control, but rather reflected a complex combination of age, education level, and number of daily injections associated with achieving good control.

Entities:  

Mesh:

Year:  1992        PMID: 1583926     DOI: 10.1097/00005650-199205001-00010

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  37 in total

1.  The SF-36 as a health status measure for epilepsy: a psychometric assessment.

Authors:  A Jacoby; G A Baker; N Steen; D Buck
Journal:  Qual Life Res       Date:  1999-06       Impact factor: 4.147

2.  Estimation and comparison of derived preference scores from the SF-36 in lung transplant patients.

Authors:  Francis S Lobo; Cynthia R Gross; Barbara J Matthees
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

3.  Multivariate analysis of health status scores: chronic airway disorders and the MOS SF-36.

Authors:  E R Cox; C M Kozma; C E Reeder
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

4.  Associations between health care factors and self-reported health status among individuals with diabetes: results from a community assessment.

Authors:  Justin B Dickerson; Matthew L Smith; SangNam Ahn; Marcia G Ory
Journal:  J Community Health       Date:  2011-04

5.  Health-related quality of life and quality of life in type 2 diabetes: relationships in a cross-sectional study.

Authors:  Murali Sundaram; Jan Kavookjian; Julie Hicks Patrick
Journal:  Patient       Date:  2009-06-01       Impact factor: 3.883

6.  Putting Wilson and Cleary to the test: analysis of a HRQOL conceptual model using structural equation modeling.

Authors:  Karen H Sousa; Oi-Man Kwok
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

7.  International Quality of Life Assessment (IQOLA) Project.

Authors:  N K Aaronson; C Acquadro; J Alonso; G Apolone; D Bucquet; M Bullinger; K Bungay; S Fukuhara; B Gandek; S Keller
Journal:  Qual Life Res       Date:  1992-10       Impact factor: 4.147

8.  Health-related quality of life in relation to metabolic control and late complications in patients with insulin dependent diabetes mellitus.

Authors:  K Wikblad; J Leksell; L Wibell
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

9.  Biological, psychosocial, and sociodemographic variables associated with depressive symptoms in persons with type 2 diabetes.

Authors:  Joseph Keawe'aimoku Kaholokula; Stephen N Haynes; Andrew Grandinetti; Healani K Chang
Journal:  J Behav Med       Date:  2003-10

10.  Predictors of quality of life of patients with type 2 diabetes.

Authors:  Ruth Kalda; Anneli Rätsep; Margus Lember
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.